Mediar Therapeutics is based in Boston. It has raised $181M in total funding. Latest round: Series A. Backed by Amplitude Ventures, ICG, Longwood Fund.
Mediar Therapeutics is based in Boston. Mediar Therapeutics has raised $181M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in March 2023. The round record for Mediar Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Amplitude Ventures, ICG, Longwood Fund, Asahi Kasei Pharma Ventures, Alexandria Real Estate Trust, Novartis Venture Fund and 9 others. 15 distinct backers are named across the disclosed rounds.
We update the Mediar Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Boston and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026